Nitazoxanide Is an Ineffective Treatment of Chronic Norovirus in Patients With X-Linked Agammaglobulinemia and May Yield False-Negative Polymerase Chain Reaction Findings in Stool Specimens-Reference-Cited by-同舟云学术

Nitazoxanide Is an Ineffective Treatment of Chronic Norovirus in Patients With X-Linked Agammaglobulinemia and May Yield False-Negative Polymerase Chain Reaction Findings in Stool Specimens

Published:2017-01-25 Issue:3 Volume:215 Page:486-487
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Kempf Bjoern,Edgar J. David,Mc Caughey Conall,Devlin Lisa A.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/215/3/486/10878255/jiw497.pdf

Reference3 articles.

1. Advances toward a norovirus antiviral: from classical inhibitor to lethal mutagenesis;J Infect Dis,2016

2. Nitazoxanide: A first-in-class broad-spectrum antiviral agent;Antiviral Res,2014

3. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human norovirus cultivation systems and their use in antiviral research;Journal of Virology;2024-04-16

2. The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review;Journal of Clinical Medicine;2024-03-16

3. Case report: Rapidly progressive neurocognitive disorder with a fatal outcome in a patient with PU.1 mutated agammaglobulinemia;Frontiers in Immunology;2024-03-04

4. Sapovirus infection as another cause of persistent viral diarrhea: case series and review of the literature;European Journal of Clinical Microbiology & Infectious Diseases;2023-11-04

5. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity;Antimicrobial Agents and Chemotherapy;2023-10-18